ArticleCureus2026
Intrahepatic Cholangiocarcinoma: The Weight of History.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cholangiocarcinoma (CCA) is a malignant tumor arising from the epithelial cells of the bile ducts. Its incidence is increasing, and it is associated with a high mortality rate due to its aggressive behavior and frequent late diagnosis. We report the case of a 52-year-old man with a history of dyslipidemia and active smoking who was brought to the emergency department following a suicide attempt. The patient suspected he had a neoplastic disease, similar to the CCA that had affected his mother. He reported a three-month history of weight loss, asthenia, fever, and night sweats. Laboratory evaluation revealed inflammatory anemia. He also reported consumption of unpasteurized cheese at symptom onset, prompting hospital admission for etiological investigation. Computed tomography scan (CT scan) of the abdomen and pelvis demonstrated calcified hilar lymphadenopathy and other slightly globular, nonspecific lymph nodes. Extensive laboratory testing, such as bone marrow aspirate, bone biopsy, and gastrointestinal endoscopic studies, revealed no primary tumor. After discharge, an 18F-FDG PET-CT scan showed findings compatible with metastatic disease - hepatic uptake (single lesion), multifocal bone involvement, and intestinal uptake. Biopsy of a bone lesion confirmed metastasis from an undifferentiated carcinoma of unknown primary, and treatment was initiated. The clinical course was unfavourable. Clinical autopsy revealed a high-grade intrahepatic CCA with bone metastases. This case illustrates an atypical presentation of intrahepatic CCA manifesting as metastatic disease of an unknown primary tumor and underscores the diagnostic challenges associated with this malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.